ALICE MELVIN: Open Payments
NPI 1568174704 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 9 payments from 6 companies in 2025. Trend: 2023 $36 · 2024 $282 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $82 |
| Organon LLC | 1 | $29 |
| Lilly USA, LLC | 1 | $24 |
| Novo Nordisk Inc | 1 | $20 |
| Exeltis, USA Inc. | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: QULIPTA, VRAYLAR, NEXPLANON, MOUNJARO, Ozempic, SLYND, ELIQUIS.
Industry payments across MD — which companies pay providers there.
